Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.1171 | 0.5 | 0.5 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.1171 | 0.5 | 0.5 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.1171 | 0.5 | 0.5 |
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.1171 | 0.5 | 0.5 |
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.1171 | 0.5 | 0.5 |
Leishmania major | 0.1171 | 0.5 | 0.5 | |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.1171 | 0.5 | 0.5 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.1171 | 0.5 | 0.5 |
Toxoplasma gondii | fructose-bisphospatase II | 0.1171 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Drug metabolism (ADMET) | Drug metabolism assessed as CYP1A2 (unknown origin)-mediated metabolite formation at 10 uM incubated for 60 mins in presence of NADPH by uHPLC-MS/MS method | ChEMBL. | 25309681 | |
Drug metabolism (ADMET) | Drug metabolism assessed as CYP3A7 (unknown origin)-mediated metabolite formation at 10 uM incubated for 60 mins in presence of NADPH by uHPLC-MS/MS method | ChEMBL. | 25309681 | |
K (ADMET) | = 0.0057 /min | Activity of CYP2B6 (unknown origin) assessed as maximum depletion rate constant pre-incubated for 5 mins in presence of NADPH by uHPLC-MS/MS based substrate depletion kinetics assay | ChEMBL. | 25309681 |
Km (ADMET) | = 0.23 uM | Activity of CYP2B6 (unknown origin) pre-incubated for 5 mins in presence of NADPH by uHPLC-MS/MS based substrate depletion kinetics assay | ChEMBL. | 25309681 |
Vmax (ADMET) | = 0.13 pmol/min | Activity of CYP2B6 (unknown origin) assessed per pmol protein pre-incubated for 5 mins in presence of NADPH by uHPLC-MS/MS based substrate depletion kinetics assay | ChEMBL. | 25309681 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.